Health Tech

Glen Tullman, Transcarent

Glen Tullman, Transcarent

A couple of weeks back Transcarent completed its $630m acquisition of Accolade. But CEO Glen Tullman calls it a merger for a reason because Accolade brings people, products and clients that ...

Show next
Som2ny Network
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart